FDA Drug Approval, N019071, UROCIT-K
FDA Drug Approval, N019071, UROCIT-K
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 019071
Company: MISSION PHARMA
Drug Name: UROCIT-K
Active Ingredients: POTASSIUM CITRATE
Strength: 15MEQ
Dosage Form/Route: TABLET, EXTENDED RELEASE;ORAL
Action Date: 08/30/1985
Marketing Status: Prescription
Submission Classification: Type 3 - New Dosage Form
Company: MISSION PHARMA
Drug Name: UROCIT-K
Active Ingredients: POTASSIUM CITRATE
Strength: 15MEQ
Dosage Form/Route: TABLET, EXTENDED RELEASE;ORAL
Action Date: 08/30/1985
Marketing Status: Prescription
Submission Classification: Type 3 - New Dosage Form
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details